Shortage of eligible patients for COVID-19 clinical trials warning
Gilead’s suspension of COVID-19 trials in China because of a shortage of suitable participants should serve as bellwether for studies in other countries, says GlobalData
Published
Join OnMedica and benefit from:
- Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
- High-quality, evidence-based content developed by expert editors and clinicians
- Articles, quizzes, videos, visual summaries and more
- Regulatory alerts and round-up of medical journals
- New content added daily, so you know you’re always up to date